Recombinant tissue‐type plasminogen activator treatment in an extremely low birth weight infant

Tissue plasminogen activator can effectively treat clinical thrombosis in premature infants 11 hours after birth.

Detalles Bibliográficos
Autores principales: Kurimoto, Tomonori, Shimoji, Yoshikazu, Shimabukuro, Atsuya, Ohshiro, Tatsuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123542/
https://www.ncbi.nlm.nih.gov/pubmed/34026194
http://dx.doi.org/10.1002/ccr3.4236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123542/
https://www.ncbi.nlm.nih.gov/pubmed/34026194
http://dx.doi.org/10.1002/ccr3.4236

Ejemplares similares